New Brunswick, NJNCT07348679Now EnrollingIRB Ready

Smoking ( Cigarette) Clinical Trial in New Brunswick, NJ

Access cutting-edge smoking ( cigarette) treatment through this clinical trial at a research site in New Brunswick. Study-provided care at no cost to qualified participants.

Sponsored by Rutgers, The State University of New Jersey

Quick Self-Assessment

See if you qualify for this New Brunswick location

Preparing your pre-screening questions…

Expert Care in New Brunswick

Access smoking ( cigarette) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related smoking ( cigarette) treatment provided free

Apply for This New Brunswick Location

Check if you qualify for this smoking ( cigarette) clinical trial in New Brunswick, NJ

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to New Brunswick

    Convenient for NJ residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit New Brunswick site if eligible
  4. 4Begin participation

About This Smoking ( Cigarette) Study in New Brunswick

The overall purpose of this study is to determine the effects of using charcoal-filtered cigarettes on product perceptions, smoking behaviors, and biomarkers of exposure to tobacco-related toxicants. The main questions it aims to answer are: Do perceptions of cigarettes differ by their filter? Do people smoke charcoal-filtered cigarettes differently than cigarettes with conventional filters, and does this change their exposure to cigarette harms? Study participants will complete a 5-week laboratory-based, open-label, parallel-design randomized trial. After a baseline period of smoking their preferred brand, participants will smoke charcoal-filtered or non-charcoal-filtered cigarettes for 4 weeks while completing weekly sessions to assess primary outcomes. During weekly sessions, they will smoke two cigarettes in our laboratory, provide urine and carbon monoxide samples, and complete questionnaires.

Sponsor: Rutgers, The State University of New Jersey

Who Can Participate

Inclusion Criteria

Eligible subjects will be:
Male and female smokers who are at least 21 years of age and self-report smoking at least 5 cigarettes per day for at least the past 6 months.
Smokers of primarily non-menthol cigarettes of brands other than Natural American Spirit.
Not currently undergoing smoking cessation treatment or trying to quit.
Able to communicate fluently in English (speaking, writing, and reading).
Capable of giving written informed consent, which includes compliance with the requirements and restrictions listed in the combined consent and HIPAA form.

Exclusion Criteria

Subjects who self-report and/or present with the following criteria will not be eligible to participate in the study: Smoking Behavior
Use of menthol or Natural American Spirit cigarettes as preferred/regular brand (defined as using \>20% of the time).
Enrollment or plans to enroll in a smoking cessation program in the next month.
Provide an initial Carbon Monoxide (CO) reading \< 5 parts per million (ppm). Alcohol/Drugs
History of substance abuse (other than nicotine) in the past 12 months and/or currently receiving medical treatment for substance abuse.
Current alcohol consumption that exceeds 25 standard drinks/week. Medical
Women who are pregnant, planning a pregnancy, and/or lactating.
Any impairment including, but not limited to, visual, physical, and/or neurological impairments preventing the completion of procedures included within this protocol. Notable impairments will be evaluated by the PI and eligibility will be determined on a case-by-case basis.
Color blindness.
Serious or unstable disease within the past 12 months (e.g. heart disease, cancer). Applicable conditions will be evaluated by the Principal Investigator and eligibility will be determined on a case-by-case basis. Psychiatric As determined by self-report:
Lifetime history or current diagnosis of psychosis, bipolar disorder, and/or schizophrenia.
Current diagnosis of major depression. Subjects with a history of major depression, in remission for 6 months or longer, are considered eligible. Other Additionally, participants may be deemed ineligible for any of the following general reasons at any point throughout the study, as well as during the initial telephone screen, at the discretion of the PI:
Significant non-compliance with protocol and/or study design.
Past, current, anticipated, or pending enrollment in another research program over the study period that could potentially impact study data.
Any medical condition, illness, disorder, adverse event (AE), or concomitant medication that could compromise participant safety or significantly impact study performance.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in New Brunswick?

Yes, this clinical trial (NCT07348679) has an active research site in New Brunswick, NJ that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Smoking ( Cigarette) Treatment Options in New Brunswick, NJ

If you're searching for smoking ( cigarette) treatment options in New Brunswick, NJ, this clinical trial (NCT07348679) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our New Brunswick research site is actively enrolling participants for this clinical trial. You'll receive care from experienced smoking ( cigarette) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all smoking ( cigarette) clinical trials near you to find additional studies recruiting in your area.

More Essential Tremor Trials in New Brunswick, NJ

See all essential tremor clinical trials recruiting in New Brunswick — not just this study.

Browse Essential Tremor Trials in New Brunswick →

Browse More Trials by Condition

Essential Tremor TrialsGeographic Atrophy TrialsAll Conditions →

Ready to Join in New Brunswick?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · New Brunswick, NJ